Does VENETOCLAX Cause Myelosuppression? 1,864 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,864 reports of Myelosuppression have been filed in association with VENETOCLAX (Venclexta). This represents 3.5% of all adverse event reports for VENETOCLAX.
1,864
Reports of Myelosuppression with VENETOCLAX
3.5%
of all VENETOCLAX reports
84
Deaths
756
Hospitalizations
How Dangerous Is Myelosuppression From VENETOCLAX?
Of the 1,864 reports, 84 (4.5%) resulted in death, 756 (40.6%) required hospitalization, and 137 (7.3%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VENETOCLAX. However, 1,864 reports have been filed with the FAERS database.
What Other Side Effects Does VENETOCLAX Cause?
Death (9,412)
Off label use (6,252)
Neutropenia (3,041)
Febrile neutropenia (2,663)
Platelet count decreased (2,367)
Pyrexia (2,351)
Pneumonia (2,300)
Fatigue (2,281)
Diarrhoea (2,082)
White blood cell count decreased (1,913)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
METHOTREXATE (1,523)
Which VENETOCLAX Alternatives Have Lower Myelosuppression Risk?
VENETOCLAX vs VENLAFAXINE
VENETOCLAX vs VENTAVIS
VENETOCLAX vs VENTOLIN
VENETOCLAX vs VENTOLIN HFA
VENETOCLAX vs VERAPAMIL